Tonix is Preparing for Potential Launch of TNX-102 SL for the management of fibromyalgia with U.S. FDA PDUFA goal date of August 15, 2025 ...

Now a third option is available after the U.S. Food and Drug Administration last week approved Vertex Pharmaceuticals’ Suzetrigine, sold as twice-daily Journavx, a non-addictive prescription drug for ...

Along with this increase, there has been a jump both in ER visits by people of all age groups who have inadvertently taken ...

Federal officials on Thursday approved a new type of pain pill designed to eliminate the risks of addiction and overdose ...

On Jan. 30, the U.S. Food and Drug Administration (FDA) approved a new drug called suzetrigine to treat moderate-to-severe ...

The program is being launched with the help of money awarded to Kentucky in settlements with pharmacies that helped fuel the ...

The shelter beds will serve homeless people recovering from substance use disorder and include wraparound services, but are ...

Rutgers Health, in partnership with the New Jersey Department of Labor and Workforce Development (NJDOL), has launched the ...

President Donald Trump's threat of tariffs on goods from Mexico, Canada and China is aimed at stopping the flow of fentanyl ...

By offering no-cost treatment, the organization hopes to bring attention to the financial barriers that prevent people from ...

The opioid epidemic continues to affect hundreds of thousands of people, but there may be hope for the future with a new, non ...

Public health experts have concerns about the opioid reversal agent Opvee. But the company that makes it, Indivior, has found ...